@incollection{,
	
					
					
					5EE5648D333A732533076FE45C01B0B8
				,
	author={{ToshimasaNakada} and {Aomori Prefectural Central Hospital}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}1541517
}

@incollection{b0,
	
	
		,
	title={{}}
		,
	author={{
			JCBurns
		} and {
			Glod
		} and {
			MPKawasaki Syndrome
		}}
		
		
	
	
		,
	journal={{Lancet}}
		
			364
			
			,
	year={2004}
		
	

}

@incollection{b1,
	
	
		,
	title={{Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions}}
		,
	author={{
			FMuller
		} and {
			WKnirsch
		} and {
			PHarpes
		} and {
			RPretre
		} and {
			BEValsangiacomo
		} and {
			OKretschmar
		}}
		
		
		
		
		
	
	
		,
	journal={{Clin Res Cardiol}}
		
			98
			
			,
	year={2009}
		
	

}

@incollection{b2,
	
	
		,
	title={{Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease}}
		,
	author={{
			ETsuda
		} and {
			TKamiya
		} and {
			YOno
		} and {
			KKimura
		} and {
			KKurosaki
		} and {
			SEchigo
		}}
		
		
		
		
		
	
	
		,
	journal={{Pediatr Cardiol}}
		
			26
			
			,
	year={2005}
		
	

}

@incollection{b3,
	
	
		,
	title={{Prevention of large coronary artery lesions caused by Kawasaki disease}}
		,
	author={{
			TNakada
		}}
		10.18103/mra.v0i3.138
		
	
	
		,
	journal={{Medical Research Archives}}
		
			,
	year={2015}
		
	

}

@incollection{b4,
	
	
		,
	title={{High-dose intravenous gammaglobulin for Kawasaki disease}}
		,
	author={{
			KFurusho
		} and {
			TKamiya
		} and {
			HNakano
		}}
		
		
	
	
		,
	journal={{Lancet}}
		
			2
			
			,
	year={1984}
		
	

}

@incollection{b5,
	
	
		,
	title={{Single intravenous infusion of gamma globulin as compared with four infusion in the treatment of acute Kawasaki syndrome}}
		,
	author={{
			JWNewburger
		} and {
			MTakahashi
		} and {
			ASBeiser
		}}
		
		
	
	
		,
	journal={{N Engl J Med}}
		
			324
			
			,
	year={1991}
		
	

}

@incollection{b6,
	
	
		,
	title={{Research committee of the Japanese Scociety of Pediatric Cardiology; Cardiac Surgery committee for development of guidelines for medical treatment of acute Kawasaki disease. Guidelines for medical treatment of acute Kawasaki disease: report of the Research committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version)}}
	
	
		,
	journal={{Pediatr Int}}
		
			56
			
			,
	year={2014}
		
	

}

@incollection{b7,
	
	
		,
	title={{Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomized, open-label, blinded-endpoints trial}}
		,
	author={{
			TKobayashi
		} and {
			TSaji
		} and {
			TOtani
		}}
		
		
	
	
		,
	journal={{Lancet}}
		
			379
			
			,
	year={2012}
		
	

}

@incollection{b8,
	
	
		,
	title={{Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial}}
		,
	author={{
			AHTremoulet
		} and {
			SJain
		} and {
			PJaggi
		}}
		
		
	
	
		,
	journal={{Lancet}}
		
			383
			
			,
	year={2014}
		
	

}

@incollection{b9,
	
	
		,
	title={{Background factors associated with the complications of coronary artery lesions caused by Kawasaki disease}}
		,
	author={{
			TNakada
		}}
	
	
		,
	journal={{Clinical Medicine Research}}
		
			4
			
			,
	year={2015}
		
	

}

@incollection{b10,
	
	
		,
	title={{Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease}}
		,
	author={{
			TYahata
		} and {
			CSuzuki
		} and {
			AYoshikawa
		}}
		
		
	
	
		,
	journal={{Circ J}}
		
			78
			
			,
	year={2014}
		
	

}

@incollection{b11,
	
	
		,
	title={{Salicylate for the treatment of Kawasaki disease in children}}
		,
	author={{
			JHBaumer
		} and {
			SJLove
		} and {
			AGupta
		}}
		
		
	
	
		,
	journal={{Cochrane Database Syst Rev}}
		
			4
			D004175
			,
	year={2006 Oct 18}
		
	

}

@incollection{b12,
	
	
		,
	title={{Treatment of acute Kawasaki disease: aspirin's role in the febril stage revisited}}
		,
	author={{
			KSHsieh
		} and {
			KPWeng
		} and {
			CCLin
		}}
		
		
	
	
		,
	journal={{Pediatrics}}
		
			114
			
			,
	year={2004}
		
	

}

@incollection{b13,
	
	
		,
	title={{Is high-dose aspirin necessary in the acute phase of Kawasaki disease?}}
		,
	author={{
			GLee
		} and {
			SELee
		} and {
			YMHong
		}}
		
		
	
	
		,
	journal={{Korean Circ J}}
		
			43
			
			,
	year={2013}
		
	

}

@incollection{b14,
	
	
		,
	title={{Effectiveness of aspirin therapy in acute phase of Kawasaki disease}}
		,
	author={{
			HIto
		} and {
			NKiyosawa
		}}
		
	
	
		,
	journal={{Prog Med}}
		
			22
			
			,
	year={2002}
		
	

}

@incollection{b15,
	
	
		,
	title={{Difference in the prevalence of coronary arterial lesions in Kawasaki disease according to the time of initiation of additional aspirin or flurbiprofen therapy}}
		,
	author={{
			TNakada
		}}
	
	
		,
	journal={{Med J Aomori}}
		
			57
			
			,
	year={2012}
		
	

}

@incollection{b16,
	
	
		,
	title={{Effects of anti-inflammatory drugs on intravenous immunoglobulin therapy in the acute phase of Kawasaki disease}}
		,
	author={{
			TNakada
		}}
	
	
		,
	journal={{Pediatr Cardiol}}
		
			36
			
			,
	year={2015}
		
	

}

@incollection{b17,
	
	
		,
	title={{Zizyphus lotus L. (Desf.) modulates antioxidant activity and human T-cell proliferation}}
		,
	author={{
			CBenammar
		} and {
			AHichami
		} and {
			AYessouufou
		}}
		
		
	
	
		,
	journal={{BMC Complement Altern Med}}
		
			10
			54
			,
	year={2010}
		
	

}

@incollection{b18,
	
	
		,
	title={{Aspirin and the induction of tolerance by dendritic cells}}
		,
	author={{
			MBuckland
		} and {
			GLombardi
		}}
		
	
	
		,
	journal={{Handb Exp Pharmacol}}
		
			188
			
			,
	year={2009}
		
	

}

@incollection{b19,
	
	
		,
	title={{The novel phospho-non-steroidal anti-inflammatory drugs, OXT-328, MDC-22 and MDC-917, inhibit adjuvantinduced arthritis in rats}}
		,
	author={{
			LHuang
		} and {
			GMackenzie
		} and {
			NOuyang
		}}
		
		
	
	
		,
	journal={{Br J Pharmacol}}
		
			162
			
			,
	year={2011}
		
	

}

@incollection{b20,
	
	
		,
	title={{Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice}}
		,
	author={{
			YInoue
		} and {
			TKaifu
		} and {
			ASugahata-Tobinai
		}}
		
		
	
	
		,
	journal={{J Immunol}}
		
			179
			
			,
	year={2007}
		
	

}

@incollection{b21,
	
	
		,
	title={{The inhibitory effects of intravenous administration of rabbit immunoglobulin G on airway inflammation are dependent upon Fcc receptor II b on CD11c(?) dendritic cells in a murine model}}
		,
	author={{
			MYamamoto
		} and {
			KKobayashi
		} and {
			YIshikawa
		}}
		
		
	
	
		,
	journal={{Clin Exp Immunol}}
		
			162
			
			,
	year={2010}
		
	

}

@incollection{b22,
	
	
		,
	title={{Changes in CD69, CD25 and HLA-DR expressions in peripheral blood T cells in Kawasaki disease}}
		,
	author={{
			YYZhang
		} and {
			XMHuang
		} and {
			MLKang
		}}
		
		
	
	
		,
	journal={{Zhonghua Er Ke Za Zhi}}
		
			44
			
			,
	year={2006}
		
	

}

@incollection{b23,
	
	
		,
	title={{A case report of refractory Kawasaki disease with bilateral giant coronary aneurysms treated with intravenous immunoglobulin and prednisolone combination therapy}}
		,
	author={{
			AAshida
		} and {
			NOzaki
		} and {
			KKishi
		} and {
			HKatayama
		} and {
			KOkasora
		} and {
			HTamai
		}}
		
		
		
		
		
	
	
		,
	journal={{Progress in Medicine}}
		
			33
			
			,
	year={2013}
		
	

}